Schmid PS, McArthur HL, Cortes J, Xu B, et al. Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial. Ann Oncol 2025 Dec 19:S0923-7534(25)06332-X. doi: 10.1016/j.annonc.2025.
PMID: 41422862